Press Kits
We have bundled all the facts and relevant background information on particularly important topics in press kits. An overview of all topic collections in chronological order can be found here.
2024
-
Quarterly Statement Q3 2024
Read MoreThe company accelerated its growth in the third quarter of 2024. All three business sectors achieved organic increases in sales and earnings.
-
Half-Yearly Financial Report Q2/2024
Read MoreThanks to the good business performance of Healthcare and Electronics, Group sales in the second quarter of 2024 increased by 1.7% organically.
-
Q1/2024: Off to a Good Start in Fiscal 2024
Read MoreThe positive development of Healthcare and Electronics largely compensated for the decline in Life Science.
-
Annual General Meeting 2024 Approves All Agenda Items
Read MoreMerck KGaA, Darmstadt, Germany held its 29th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, including the proposed dividend of € 2.20 per share.
-
Fiscal 2023: Proven resilience during transitional year
Read MoreThe Group reported financial results for 2023 in line with its guidance published in August despite a challenging market environment, thus demonstrating the robustness of its business model.
2023
-
Q3 2023: Group Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
Read moreThe strong organic development of the Healthcare business sector partly compensated for the decline in sales and earnings in Life Science and Electronics.
-
Q2 2023: Demonstrating resilience under market pressure
Read moreIn the second quarter of 2023, the Group leveraged its diversified portfolio to navigate a challenging market environment.
-
Quarterly Statement Q1 2023
Read moreMerck KGaA, Darmstadt, Germany generated net sales of € 5.3 billion in the first quarter of 2023. This corresponds to an increase of 1.8% over the year-earlier quarter (organically 0.8%).
-
Fiscal 2022: Profitable growth despite challenges
Read moreIn fiscal 2022, the Group delivered solid growth in net sales and EBITDA pre.
2022
-
Access to Medicine
Find out more2022/11/15 - Every two years, the Access to Medicine Foundation, an independent non-profit organization founded in 2005, benchmarks 20 of the world’s largest pharmaceutical companies based on their efforts to advance global access to medicines.
-
Quarterly Statement Q3 2022
Read moreGroup Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3
-
Q2 2022: Group Delivers Robust Growth Despite Headwinds
Read moreWe continued our growth trajectory in the second quarter of 2022 despite a challenging environment. Group net sales rise by 14.3% to € 5.6 billion.
-
Our contributions to the fight against Covid-19
Read moreHow we are contributing to the global Covid-19 response.
-
First Quarter: Strong Start into Fiscal 2022
Our growth story continues to materialize. Group sales increased organically by 7.8% to € 5.2 billion compared with the year-earlier quarter. Detailed information about our business in the first quarter of 2022.Read more -
Annual General Meeting 2022
2022/04/22 - Here you will find detailed information about the Annual General Meeting 2020 of Merck KGaA, Darmstadt, Germany.Read more -
Sustainability Report 2021
2022/04/12 - We transparently inform our stakeholders about our activities and successes, along with the challenges we face. Every year, we publish a comprehensive report on our progress, goals and efforts worldwide.Go to Report -
Record Growth - Fiscal 2021
Group delivered record growth in fiscal 2021. All three business sectors, first and foremost Life Science, contributed to sales growth.Read more -
CES 2022: Discussing Future Trends in Electronics
Our company will present its latest technology advancements for the electronics industry at the Consumer Electronics Show (CES) 2022. Four panel stage talks will cover innovation in the electronics industry; these will be available in person and virtually.Read More
2021
-
Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth
Group again grew strongly in the third quarter of 2021. Net sales amounted to € 5.0 billion. EBITDA pre, the most important financial indicator to steer operating business, reached € 1.6 billion.Read more -
Strong Second Quarter
The Group achieved outstanding business results in Q2 2021, also driven by the soft, pandemic-impacted year-earlier quarter, and now updated and raised the forecast for fiscal 2021.Read more -
First Quarter of 2021: Great Strength in Challenging Market Environment
Group sales increased by 6.0% to € 4.6 billion, EBITDA pre soared by 27.9% to € 1.5 billion, forecast for fiscal 2021 raised.Read more -
Financial Results 2020: Group Reports Record Results in a Turbulent Year
Group had a successful fiscal 2020, a year that was marked by the Covid-19 pandemic. The company met all the financial targets it had set for itself.Read more -
We are Electronics
Our new name reflects what we do. We are building next generation solutions from the atom up. Electronics starts with us.Read more
2020
-
Merck KGaA, Darmstadt, Germany at CES 2021: Materials and Solutions for Advancing Digital Living
Read moreMerck KGaA, Darmstadt, Germany, will present its latest technology advancements for the electronics industry at the Consumer Electronics Show (CES) 2021.
-
Publication of the results for the 3rd quarter of 2020
Merck KGaA, Darmstadt, Germany grew significantly in the third quarter. In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion.Read more -
Hall of Fame der deutschen Forschung 2020
In an event held virtually for the first time, the hosts manager magazin and us honored the laureate of the Hall of Fame der deutschen Forschung 2020: Emmanuelle Charpentier, as well as the two awardees of the Curious-Mind-Forscherpreis, Siegfried Rasthofer and Björn Eskofier.Read more -
Q2 2020: Group Remains on Course
Sales rise by 3.7% to € 4.1 billion, EBITDA pre declines by -5.7% to € 1.1 billionRead more -
Virtual Annual General Meeting 2020
2020/05/28 - Here you will find detailed information about the Annual General Meeting 2020 of Merck KGaA, Darmstadt, Germany.Read more -
Q1/2020: Quarterly statement
2020/05/14 - Strong first quarter - low impact from Covid-19 to date. Group grew profitably in the first quarter of 2020. Net sales rose by 16.7%, EBITDA pre grew by 27.2%.Read more -
Results 2019: All Financial Targets Met
2020/03/05 - Merck KGaA, Darmstadt, Germany, met all financial targets for fiscal 2019, achieved profitable growth and made significant strategic progress.Find out more
-
SCHISTOSOMIASIS ELIMINATION PROGRAM
2020/02/12 - Merck KGaA, Darmstadt, Germany initiated its Schistosomiasis Elimination Program in cooperation with WHO back in 2007 and has committed itself to fight against the tropical disease until it has been eliminated.Find out more
-
CES 2020
Advancing Digital Living – We presented our latest innovations for the electronics industry at the Consumer Electronics Show (CES), the world’s largest electronics tradeshow taking place in Las Vegas from January 7-10, 2020.Find out more
2019
-
Q3 2019: Financial Results
2019/11/14 - Merck KGaA, Darmstadt, Germany generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019.Find out more
-
Half-yearly Financial Report 2019
2019/08/08 - Merck KGaA, Darmstadt, Germany sees profit jump in Q2. EBITDA pre up sharply, organically driven by Life Science and Healthcare.Find out more
-
Future insight prize
2019/07/09 - Stimulating scientific and technological progress in the areas of health, nutrition, and energy. The Future Insight Prize builds a network of innovators to enable the dreams for a better tomorrow.Find out more
-
Quarterly Statement Q1/2019
2019/05/14 - Forecast for organic performance in 2019 confirmed. We significantly increased net sales in the first quarter of 2019, primarily on an organic basis.Find out more
-
ANNUAL GENERAL MEETING 2019
2019/04/26 - After Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany, briefly recapitulated the anniversary year 2018, he presented the company’s plans for future growth to our shareholders.Find out more
2018
-
Fiscal Year 2018
2019/03/07 - Merck KGaA, Darmstadt, Germany achieves 2018 targets and is set for profitable growth. Successful finish to a challenging 2018 – organic sales increase driven by all business sectors and regionsFind out more
2017
-
Lab water purification
2017/03/19 - Water affects all facets of life. Nothing flourishes and nothing grows without it. Water is especially important for scientists, as an essential element in all chemical, pharmaceutical and food and beverage testing around the world.Find out more